{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MDCX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":4.06,"timestamp":1745265600000,"preClose":4,"halted":0,"volume":62372,"hourTrading":{"tag":"盘后","latestPrice":4.03,"preClose":4.06,"latestTime":"16:22 EDT","volume":514,"amount":2070.04,"timestamp":1745266956700},"delay":0,"floatShares":5737800,"shares":13414801,"eps":0,"marketStatus":"Not Yet Opened","change":0.06,"latestTime":"04-21 16:00:00 EDT","open":4.33,"high":4.33,"low":3.61,"amount":253666.29624,"amplitude":0.18,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":4,"preHourTrading":{"tag":"盘前","latestPrice":4.23,"preClose":4,"latestTime":"09:29 EDT","volume":354,"amount":1549.0799279999999,"timestamp":1745242170011},"postHourTrading":{"tag":"盘后","latestPrice":4.03,"preClose":4.06,"latestTime":"16:22 EDT","volume":514,"amount":2070.04,"timestamp":1745266956700},"volumeRatio":2.422496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":5737800,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.422496,"shares":13414801,"dividePrice":0,"high":4.33,"amplitude":0.18,"preClose":4,"low":3.61,"week52Low":1.8,"pbRate":"--","week52High":4.99,"institutionHeld":0,"latestPrice":4.06,"eps":0,"divideRate":0,"volume":62372,"delay":0,"ttmEps":0,"open":4.33,"prevYearClose":2.43,"prevWeekClose":4,"prevMonthClose":3.72,"prevQuarterClose":3.72,"fiveDayClose":3.579,"twentyDayClose":3.3184,"sixtyDayClose":2.81},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MDCX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529618805","title":"Medicus Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2529618805","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529618805?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:27","pubTimestamp":1745238420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDCX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 08:27 ET (12:27 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"gpt_icon":0},{"id":"2529703568","title":"Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529703568","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529703568?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:30","pubTimestamp":1745235000,"startTime":"0","endTime":"0","summary":"The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty  to Ninety .The Company to Expand the Study into Additional Trial Sites in Europe. The phase 2 clinical study  which is currently underway in nine  clinical sites in United States will expand into additional sites in United States, as well as two clinical trial sites in Europe.The Company also announced that it has randomized more the forty-five  participants in the study and is on track to submit the package seeking a Type C meeting with the United States Food and Drug Administration  before the end of Q2 2025.The high-dose, 200μg D-MNA, in the study is the maximum dose that was used in the Company's Phase 1 safety and tolerability study  completed in March 2021.SKNJCT-001 met its primary objective of safety and tolerability. The investigational product, D-MNA, was well tolerated across all dose levels in all 13 participants enrolled in the study, with no dose-lim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medicus-pharma-provides-sknjct-003-113000635.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medicus-pharma-provides-sknjct-003-113000635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDCX","BK4139","UAE","BK4104","BK4567","BCC","MDCXW"],"gpt_icon":0},{"id":"2527156220","title":"Medicus Pharma Initiated at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2527156220","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527156220?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:34","pubTimestamp":1744630440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDCX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 07:34 ET (11:34 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2518970785","title":"Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518970785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518970785?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:43","pubTimestamp":1741639421,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) just unveiled an announcement. Medicus Pharma Ltd. has successfully closed a $4.2 million Tier II Regulation A offer...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-4-2-million-for-innovative-skin-treatment-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-4-2-million-for-innovative-skin-treatment-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744862400000}}}